Company profile: Snapdragon Chemistry
1.1 - Company Overview
Company description
- Provider of practical manufacturing solutions for challenging chemical transformations, including API process development, GMP drug substance manufacturing in-house or at Cambrex’s global sites, proprietary continuous process technologies, reactor build and design with 3D CAD and custom components, portfolio optimization, and complex synthetics such as block copolymers, polymeric linkers, and functionalized dendrimers.
Products and services
- GMP Manufacturing: Produces extensive drug substance manufacturing with the ability to implement GMP in its facilities or within Cambrex’s global sites, executed in a GMP-compliant manner
- Process Development: Optimizes API drug development processes, suggesting process improvement and scale-up concepts to solve complex chemistry challenges, employing custom-engineered methodologies for practical manufacturing
- Complex Synthetics: Develops and fabricates complex synthetic molecules—block copolymers, polymeric linkers, functionalized dendrimers—using advanced technologies, delivering industrial-grade products for challenging chemical transformations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Snapdragon Chemistry
Artes Biotechnology
HQ: Germany
Website
- Description: Provider of biopharmaceutical production processes and CDMO services, including microbial cell line and process development, manufacturing of test and preclinical material, and vaccine development. Offers pre-developed recombinant protein processes (biosimilars, vaccines, enzymes), technology transfer and proprietary cell line licensing; supplies recombinant reagents from yeast and bacterial platforms; and develops yeast (Hansenula polymorpha) and E. coli systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artes Biotechnology company profile →
Mapi
HQ: France
Website
- Description: Provider of patient-centered research services to the global healthcare industry, serving academia, life science researchers, and the pharmaceutical industry for over 40 years.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mapi company profile →
Biodextris
HQ: Canada
Website
- Description: Provider of analytical and process development, early-phase clinical manufacturing, packaging, and scalable bioproduction services for vaccines and biologics. Offers quality control testing and validation to ensure regulatory compliance, with tailored development solutions for biotech and pharmaceutical companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biodextris company profile →
Zenith Technologies
HQ: Ireland
Website
- Description: Provider of global full lifecycle automation, manufacturing, and operational support solutions for the life science industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zenith Technologies company profile →
ProPharma
HQ: United States
Website
- Description: Provider of independent, single-source regulatory, compliance, pharmacovigilance, and medical information services for pharmaceutical, biotechnology, and medical device companies; offering RCO custom solutions across the full product lifecycle, tailored MedTech solutions from concept to market, full-service Oncology CRO capabilities, global lifecycle solutions, and Prodigy technology to de-risk decision making and drive value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProPharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Snapdragon Chemistry
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Snapdragon Chemistry
2.2 - Growth funds investing in similar companies to Snapdragon Chemistry
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Snapdragon Chemistry
4.2 - Public trading comparable groups for Snapdragon Chemistry
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →